Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alnylam Pharmaceuticals

232.12
-2.4400-1.04%
Volume:441.81K
Turnover:102.62M
Market Cap:30.05B
PE:-106.52
High:237.77
Open:231.34
Low:228.28
Close:234.56
Loading ...
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 24, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 21, 2025

Major Issues Report

Form 8-K - Current report
Mar 05, 2025

Major Issues Report

Form 8-K - Current report
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 04, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 19, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 13, 2025

Major Issues Report

Form 8-K - Current report
Feb 13, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jan 28, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 13, 2025

Major Issues Report

Form 8-K - Current report
Dec 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Oct 31, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]